LU, Alan Y,QIN, Huanlong,LIU, Menghan,LU, Patrick Y
申请号：
EP16856629
公开号：
EP3388085A4
申请日:
2016.06.13
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
A pharmaceutical composition, comprises micro RNAs with or without chemical modification, and a carrier suitable for delivery in vivo, the carrier is a branched histidine-lysine polypeptide or modified compound thereof. The pharmaceutical composition is capable of inhibiting the growth of colon cancer by inducing programmed death of cancer cell and further be used for the manufacture of a targeted drug for colorectal cancer treatment.
